Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)

Detalhes bibliográficos
Autor(a) principal: Carvalho, Sylene Coutinho Rampche de
Data de Publicação: 2013
Outros Autores: Muniz, Maria Tereza Cartaxo, Siqueira, Maria Deozete Vieira, Siqueira, Erika Rabelo Forte, Gomes, Adriana Vieira, Silva, Karina Alves, Bezerra, Lais Carvalho Luma, D'Almeida, Vania [UNIFESP], Oliveira, Claudia Pinto Marques Souza de, Pereira, Leila Maria M. Beltrao
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1186/1475-2891-12-37
http://repositorio.unifesp.br/handle/11600/36192
Resumo: Background: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, which includes a spectrum of hepatic pathology such as simple steatosis, steatohepatitis, fibrosis and cirrhosis. the increased serum levels of homocysteine (Hcy) may be associated with hepatic fat accumulation. Genetic mutations in the folate route may only mildly impair Hcy metabolism. the aim of this study was to investigate the relation between liver steatosis with plasma homocysteine level and MTHFR C677T and A1298C polymorphisms in Brazilian patients with NAFLD.Methods: Thirty-five patients diagnosed with NAFLD by liver biopsy and forty-five healthy controls neither age nor sex matched were genotyped for C677T and A1298C MTHFR polymorphisms using PCR-RFLP and PCR-ASA, respectively, and Hcy was determined by HPLC. All patients were negative for markers of Wilson's, hemochromatosis and autoimmune diseases. Their daily alcohol intake was less than 100 g/week. A set of metabolic and serum lipid markers were also measured at the time of liver biopsies.Results: the plasma Hcy level was higher in NAFLD patients compared to the control group (p = 0.0341). No statistical difference for genotypes 677C/T (p = 0.110) and 1298A/C (p = 0.343) in patients with NAFLD and control subjects was observed. the genotypes distribution was in Hardy-Weinberg equilibrium (677C/T p = 0.694 and 1298 A/C p = 0.188). the group of patients and controls showed a statistically significant difference (p < 0.001) for BMI and HOMA_IR, similarly to HDL cholesterol levels (p < 0,006), AST, ALT, gamma GT, AP and triglycerides levels (p < 0.001). A negative correlation was observed between levels of vitamin B12 and Hcy concentration (p = 0.005).Conclusion: Our results indicate that plasma Hcy was higher in NAFLD than controls. the MTHFR C677T and A1298C polymorphisms did not differ significantly between groups, despite the 677TT homozygous frequency was higher in patients (17.14%) than in controls (677TT = 4.44%) (p > 0.05). the suggested genetic susceptibility to the MTHFR C677T and A1298C should be confirmed in large population based studies.
id UFSP_b9fc04dded344e33f226936543291beb
oai_identifier_str oai:repositorio.unifesp.br/:11600/36192
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)Fatty liverNon-alcoholic steatohepatitisMethylenetetrahydrofolate reductase (MTHFR)Oxidative stressPolymorphismsBackground: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, which includes a spectrum of hepatic pathology such as simple steatosis, steatohepatitis, fibrosis and cirrhosis. the increased serum levels of homocysteine (Hcy) may be associated with hepatic fat accumulation. Genetic mutations in the folate route may only mildly impair Hcy metabolism. the aim of this study was to investigate the relation between liver steatosis with plasma homocysteine level and MTHFR C677T and A1298C polymorphisms in Brazilian patients with NAFLD.Methods: Thirty-five patients diagnosed with NAFLD by liver biopsy and forty-five healthy controls neither age nor sex matched were genotyped for C677T and A1298C MTHFR polymorphisms using PCR-RFLP and PCR-ASA, respectively, and Hcy was determined by HPLC. All patients were negative for markers of Wilson's, hemochromatosis and autoimmune diseases. Their daily alcohol intake was less than 100 g/week. A set of metabolic and serum lipid markers were also measured at the time of liver biopsies.Results: the plasma Hcy level was higher in NAFLD patients compared to the control group (p = 0.0341). No statistical difference for genotypes 677C/T (p = 0.110) and 1298A/C (p = 0.343) in patients with NAFLD and control subjects was observed. the genotypes distribution was in Hardy-Weinberg equilibrium (677C/T p = 0.694 and 1298 A/C p = 0.188). the group of patients and controls showed a statistically significant difference (p < 0.001) for BMI and HOMA_IR, similarly to HDL cholesterol levels (p < 0,006), AST, ALT, gamma GT, AP and triglycerides levels (p < 0.001). A negative correlation was observed between levels of vitamin B12 and Hcy concentration (p = 0.005).Conclusion: Our results indicate that plasma Hcy was higher in NAFLD than controls. the MTHFR C677T and A1298C polymorphisms did not differ significantly between groups, despite the 677TT homozygous frequency was higher in patients (17.14%) than in controls (677TT = 4.44%) (p > 0.05). the suggested genetic susceptibility to the MTHFR C677T and A1298C should be confirmed in large population based studies.Univ Pernambuco, Sch Med, Recife, PE, BrazilUniv Pernambuco, Pediat Hematol & Oncol Ctr, Recife, PE, BrazilLiver Inst Pernambuco, Recife, PE, BrazilUniv Pernambuco, Inst Biol Sci, Recife, PE, BrazilUniversidade Federal de São Paulo, Dept Pediat, São Paulo, BrazilUniv São Paulo, Sch Med, São Paulo, BrazilInst Figado Pernambuco, BR-50100130 Santo Amaro Recife, BrazilUniversidade Federal de São Paulo, Dept Pediat, São Paulo, BrazilWeb of ScienceBiomed Central LtdUniv PernambucoLiver Inst PernambucoUniversidade Federal de São Paulo (UNIFESP)Universidade de São Paulo (USP)Inst Figado PernambucoCarvalho, Sylene Coutinho Rampche deMuniz, Maria Tereza CartaxoSiqueira, Maria Deozete VieiraSiqueira, Erika Rabelo ForteGomes, Adriana VieiraSilva, Karina AlvesBezerra, Lais Carvalho LumaD'Almeida, Vania [UNIFESP]Oliveira, Claudia Pinto Marques Souza dePereira, Leila Maria M. Beltrao2016-01-24T14:31:33Z2016-01-24T14:31:33Z2013-04-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion5application/pdfhttp://dx.doi.org/10.1186/1475-2891-12-37Nutrition Journal. London: Biomed Central Ltd, v. 12, 5 p., 2013.10.1186/1475-2891-12-37WOS000317666000001.pdf1475-2891http://repositorio.unifesp.br/handle/11600/36192WOS:000317666000001engNutrition Journalinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-06T15:54:15Zoai:repositorio.unifesp.br/:11600/36192Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-06T15:54:15Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
title Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
spellingShingle Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
Carvalho, Sylene Coutinho Rampche de
Fatty liver
Non-alcoholic steatohepatitis
Methylenetetrahydrofolate reductase (MTHFR)
Oxidative stress
Polymorphisms
title_short Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
title_full Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
title_fullStr Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
title_full_unstemmed Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
title_sort Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
author Carvalho, Sylene Coutinho Rampche de
author_facet Carvalho, Sylene Coutinho Rampche de
Muniz, Maria Tereza Cartaxo
Siqueira, Maria Deozete Vieira
Siqueira, Erika Rabelo Forte
Gomes, Adriana Vieira
Silva, Karina Alves
Bezerra, Lais Carvalho Luma
D'Almeida, Vania [UNIFESP]
Oliveira, Claudia Pinto Marques Souza de
Pereira, Leila Maria M. Beltrao
author_role author
author2 Muniz, Maria Tereza Cartaxo
Siqueira, Maria Deozete Vieira
Siqueira, Erika Rabelo Forte
Gomes, Adriana Vieira
Silva, Karina Alves
Bezerra, Lais Carvalho Luma
D'Almeida, Vania [UNIFESP]
Oliveira, Claudia Pinto Marques Souza de
Pereira, Leila Maria M. Beltrao
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Univ Pernambuco
Liver Inst Pernambuco
Universidade Federal de São Paulo (UNIFESP)
Universidade de São Paulo (USP)
Inst Figado Pernambuco
dc.contributor.author.fl_str_mv Carvalho, Sylene Coutinho Rampche de
Muniz, Maria Tereza Cartaxo
Siqueira, Maria Deozete Vieira
Siqueira, Erika Rabelo Forte
Gomes, Adriana Vieira
Silva, Karina Alves
Bezerra, Lais Carvalho Luma
D'Almeida, Vania [UNIFESP]
Oliveira, Claudia Pinto Marques Souza de
Pereira, Leila Maria M. Beltrao
dc.subject.por.fl_str_mv Fatty liver
Non-alcoholic steatohepatitis
Methylenetetrahydrofolate reductase (MTHFR)
Oxidative stress
Polymorphisms
topic Fatty liver
Non-alcoholic steatohepatitis
Methylenetetrahydrofolate reductase (MTHFR)
Oxidative stress
Polymorphisms
description Background: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, which includes a spectrum of hepatic pathology such as simple steatosis, steatohepatitis, fibrosis and cirrhosis. the increased serum levels of homocysteine (Hcy) may be associated with hepatic fat accumulation. Genetic mutations in the folate route may only mildly impair Hcy metabolism. the aim of this study was to investigate the relation between liver steatosis with plasma homocysteine level and MTHFR C677T and A1298C polymorphisms in Brazilian patients with NAFLD.Methods: Thirty-five patients diagnosed with NAFLD by liver biopsy and forty-five healthy controls neither age nor sex matched were genotyped for C677T and A1298C MTHFR polymorphisms using PCR-RFLP and PCR-ASA, respectively, and Hcy was determined by HPLC. All patients were negative for markers of Wilson's, hemochromatosis and autoimmune diseases. Their daily alcohol intake was less than 100 g/week. A set of metabolic and serum lipid markers were also measured at the time of liver biopsies.Results: the plasma Hcy level was higher in NAFLD patients compared to the control group (p = 0.0341). No statistical difference for genotypes 677C/T (p = 0.110) and 1298A/C (p = 0.343) in patients with NAFLD and control subjects was observed. the genotypes distribution was in Hardy-Weinberg equilibrium (677C/T p = 0.694 and 1298 A/C p = 0.188). the group of patients and controls showed a statistically significant difference (p < 0.001) for BMI and HOMA_IR, similarly to HDL cholesterol levels (p < 0,006), AST, ALT, gamma GT, AP and triglycerides levels (p < 0.001). A negative correlation was observed between levels of vitamin B12 and Hcy concentration (p = 0.005).Conclusion: Our results indicate that plasma Hcy was higher in NAFLD than controls. the MTHFR C677T and A1298C polymorphisms did not differ significantly between groups, despite the 677TT homozygous frequency was higher in patients (17.14%) than in controls (677TT = 4.44%) (p > 0.05). the suggested genetic susceptibility to the MTHFR C677T and A1298C should be confirmed in large population based studies.
publishDate 2013
dc.date.none.fl_str_mv 2013-04-02
2016-01-24T14:31:33Z
2016-01-24T14:31:33Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1186/1475-2891-12-37
Nutrition Journal. London: Biomed Central Ltd, v. 12, 5 p., 2013.
10.1186/1475-2891-12-37
WOS000317666000001.pdf
1475-2891
http://repositorio.unifesp.br/handle/11600/36192
WOS:000317666000001
url http://dx.doi.org/10.1186/1475-2891-12-37
http://repositorio.unifesp.br/handle/11600/36192
identifier_str_mv Nutrition Journal. London: Biomed Central Ltd, v. 12, 5 p., 2013.
10.1186/1475-2891-12-37
WOS000317666000001.pdf
1475-2891
WOS:000317666000001
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Nutrition Journal
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 5
application/pdf
dc.publisher.none.fl_str_mv Biomed Central Ltd
publisher.none.fl_str_mv Biomed Central Ltd
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268329341222912